Elutia (ELUT) Income from Continuing Operations (2019 - 2026)
Elutia recorded quarterly Income from Continuing Operations of 7894000.0 in Q1 2026, down 20.48% quarter-over-quarter from 6552000.0 in Q4 2025, and down 318.34% year-over-year from 3615528.64 in Q1 2025.
Elutia's Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 7894000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 318.34% year-over-year to 7894000.0; the TTM figure through Mar 2026 stood at 24439000.0 (up 28.25% YoY), while the FY2025 annual figure was 15913000.0, up 64.91% from the prior year.
- Income from Continuing Operations came in at 7894000.0 for Q1 2026 at Elutia, down from 6552000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3339000.0 in Q3 2024 to a low of 28360000.0 in Q2 2024.
- A 5-year average of 8961117.65 and a median of 8149000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations surged 139.19% in 2024 and plunged 318.34% in 2026, its largest moves.
- Elutia's Income from Continuing Operations stood at 6015000.0 in 2022, then sank by 153.07% to 15222000.0 in 2023, then soared by 53.0% to 7155000.0 in 2024, then climbed by 8.43% to 6552000.0 in 2025, then retreated by 20.48% to 7894000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 7894000.0, 6552000.0, and 383000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | -7.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.89 Mn |
| Dec 31, 2025 | -6.51 Mn |
| Sep 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -3.93 Mn |
| Dec 31, 2024 | -7.16 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | -28.36 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | -15.22 Mn |
| Sep 30, 2023 | -8.52 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -9.78 Mn |
| Dec 31, 2022 | -6.02 Mn |
| Sep 30, 2022 | -11.03 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |
| Jun 30, 2021 | -2.39 Mn |
| Mar 31, 2021 | -5.07 Mn |
| Dec 31, 2020 | -5.36 Mn |
| Sep 30, 2020 | -6.73 Mn |
| Jun 30, 2020 | -5.18 Mn |
| Mar 31, 2020 | -4.56 Mn |
| Dec 31, 2019 | -2.78 Mn |
| Sep 30, 2019 | -3.10 Mn |